SEC61 Translocon Subunit Gamma Enhances Low-Dose Cisplatin-Induced Cancer-Stem Cell Properties of Head and Neck Squamous Cell Carcinoma via Enhancing Ca²⁺-Mediated Autophagy

Scientists revealed the contribution of SEC61 translocon subunit gamma (SEC61G) in promoting cisplatin-induced CSC properties of head and neck squamous cell carcinoma cells via promoting Ca2+-mediated autophagy.